CWP
ONC icon

Concord Wealth Partners’s BeOne Medicines Ltd ONC Stock Holding History

Concord Wealth Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$924 – 992
2024
Q4 		$924 Hold
5
– – ﹤0.01% 806
2024
Q3 		$1.12K Buy
+5
New +$900 ﹤0.01% 814

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Concord Wealth Partners's ONC Position: Q1 2025 in Review

Concord Wealth Partners sold out of BeOne Medicines Ltd (ONC) in Q1 2025, closing a stake of 5 shares — an estimated $924 sold.

Concord Wealth Partners first reported a position in ONC in Q3 2024 and held it in 2 quarters. The position peaked at $1.12K in Q3 2024. 268 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

  • Concord Wealth Partners reported no remaining BeOne Medicines Ltd position as of Q1 2025 after selling out during the quarter.
  • Concord Wealth Partners sold 5 BeOne Medicines Ltd shares in Q1 2025, an estimated $924.
  • Concord Wealth Partners first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 2 quarters.
  • Concord Wealth Partners's BeOne Medicines Ltd position peaked at $1.12K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Concord Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.